Use of Rituximab to Decrease Panel-Reactive Antibodies

Patients with pre-formed antibodies may be at increased risk of rejection after organ transplantation. In this report, we describe the use of rituximab to decrease the percentage of pre-formed antibodies in a pediatric heart transplant recipient.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of heart and lung transplantation 2005-05, Vol.24 (5), p.628-630
Hauptverfasser:	Balfour, Ian C., Fiore, Andrew, Graff, Ralph J., Knutsen, Alan P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies - drug effects Antibodies - immunology Antibodies, Monoclonal - immunology Antibodies, Monoclonal - pharmacology Antibodies, Monoclonal, Murine-Derived Biological and medical sciences Cardiac Surgical Procedures Child Graft Rejection - immunology Graft Rejection - prevention & control Heart Defects, Congenital - surgery Heart Transplantation - immunology HLA Antigens - immunology Humans Immunologic Factors - immunology Immunologic Factors - pharmacology Male Medical sciences Reoperation Rituximab Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the heart
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!